Helius Medical Technologies Inc expected to post a loss of 12 cents a share - Earnings Preview

Solana Co

09/08/2023 03:01

* Helius Medical Technologies Inc  HSDT.OQ   HSDT.O  is
expected
to show a rise in quarterly revenue when it reports  results on
August 10. 
    * The Newtown Pennsylvania-based  company is expected to
report  a
58.3% increase in revenue to $188.33 thousand from $119 thousand
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Helius Medical
Technologies Inc is for a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Helius
Medical
Technologies Inc is $1.7​, above​ its last closing price
of $0.19. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.11       -0.11      -0.09     Beat    18.2
 Dec. 31 2023  -0.13       -0.13      -0.17     Missed  -30.8
 Sep. 30 2022  -0.21       -0.21      -0.03     Beat    85.7​
 Jun. 30 2022  -1.12       -1.12      -0.97     Beat    13.4
 ​​Mar.        -1.13       -1.13      -1.15     Missed  -1.8
 31 2022                                                
 Dec. 31 2021  -1.16       -1.16      -1.31     Missed  -12.9​
 Sep. 30 2021  -1.75       -1.75      -1.63     Beat    6.9
 Jun. 30 2021  -1.61       -1.61      -1.76     Missed  -9
 This summary was machine generated August 9 at 02:01 GMT.  All
figures in US dollars  unless otherwise stated